menu search

Find strong stocks for 2022 with return on equity

Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...

December 21, 2021, 8:42 pm

Find strong stocks for 2022 with return on equity

Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...

December 21, 2021, 8:42 pm

Find strong stocks for 2022 with return on equity

Today, we utilized a Zacks screen to help find highly-ranked stocks that have proven they can turn asse...

December 21, 2021, 8:42 pm

Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings

Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...

December 8, 2021, 1:27 pm

Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings

Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...

December 8, 2021, 1:27 pm

Novartis' new kisqali data shows consistent overall survival benefit across metastatic breast cancer settings

Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic br...

December 8, 2021, 1:27 pm

Metlife: proven business model with a 3.08% dividend yield

MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...

November 27, 2021, 6:40 am

Metlife: proven business model with a 3.08% dividend yield

MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...

November 27, 2021, 6:40 am

Metlife: proven business model with a 3.08% dividend yield

MetLife posted good 3rd quarter results outperforming the estimates. Their business model is stable and proven...

November 27, 2021, 6:40 am

Amazon care inks deal with hilton, yet again proving its might in innovative disruption

As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...

November 23, 2021, 10:19 pm

Amazon care inks deal with hilton, yet again proving its might in innovative disruption

As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...

November 23, 2021, 10:19 pm

Amazon care inks deal with hilton, yet again proving its might in innovative disruption

As Amazon has proven across nearly all other industries, it will undoubtedly be a force to reckon with ...

November 23, 2021, 10:19 pm

Kyndryl - unwanted and undervalued

Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...

November 23, 2021, 1:18 pm

Kyndryl - unwanted and undervalued

Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...

November 23, 2021, 1:18 pm

Kyndryl - unwanted and undervalued

Kyndryl was recently spun out of IBM and is down sharply in only three weeks of trading. KD addresses a mediocre market and is not a pr...

November 23, 2021, 1:18 pm

Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment

Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...

November 19, 2021, 7:29 pm

Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment

Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...

November 19, 2021, 7:29 pm

Arbutus biopharma: recent acquisition of dicerna makes it an attractive investment

Recent Acquisition of RNAi drug maker Dicerna by Novo Nordisk makes a case for eventual partnership/buyout of Arbutus Biopharma. AB-729 has pr...

November 19, 2021, 7:29 pm

Bioventus inc. (bvs) ceo ken reali on q3 2021 results - earnings call transcript

Bioventus Inc. (BVS) CEO Ken Reali on Q3 2021 Results - Earnings Call Transcript...

November 14, 2021, 11:45 am

Bioventus inc. (bvs) ceo ken reali on q3 2021 results - earnings call transcript

Bioventus Inc. (BVS) CEO Ken Reali on Q3 2021 Results - Earnings Call Transcript...

November 14, 2021, 11:45 am


Search within

Pages Search Results: